IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 267 filers reported holding IVERIC BIO INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,155,265 | -23.8% | 80,205 | -52.9% | 0.01% | -82.0% |
Q1 2023 | $4,140,431 | -57.6% | 170,178 | -62.7% | 0.06% | -65.7% |
Q4 2022 | $9,756,858 | -16.6% | 455,715 | -30.1% | 0.18% | -20.2% |
Q3 2022 | $11,696,000 | +98.3% | 651,951 | +6.3% | 0.22% | +36.8% |
Q2 2022 | $5,899,000 | -34.1% | 613,165 | +15.2% | 0.16% | -31.8% |
Q1 2022 | $8,956,000 | +177.5% | 532,145 | +175.8% | 0.24% | +139.0% |
Q4 2021 | $3,227,000 | +723.2% | 192,973 | +210.5% | 0.10% | +669.2% |
Q2 2021 | $392,000 | +612.7% | 62,150 | +287.0% | 0.01% | +8.3% |
Q1 2020 | $55,000 | – | 16,060 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 2,516,920 | $42,360,000 | 17.00% |
COMMODORE CAPITAL LP | 2,214,961 | $37,278,000 | 8.33% |
Ally Bridge Group (NY) LLC | 650,000 | $10,940,000 | 8.11% |
Vivo Capital, LLC | 6,431,940 | $108,250,000 | 7.45% |
Samsara BioCapital, LLC | 1,262,551 | $21,249,000 | 5.35% |
Deep Track Capital, LP | 4,500,000 | $75,735,000 | 4.86% |
ACUTA CAPITAL PARTNERS, LLC | 539,500 | $9,080,000 | 4.24% |
Paradigm Biocapital Advisors LP | 910,416 | $15,322,000 | 4.05% |
Logos Global Management LP | 1,800,000 | $30,294,000 | 3.93% |
Yiheng Capital Management, L.P. | 5,058,585 | $85,136,000 | 3.89% |